Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pennard Vets appoints first group clinical director
Serina Filler will lead clinical teams and develop new protocols across the group.
The independent vet group has welcomed Serina Filler to its team.

Pennard Vets, an independent veterinary group in Kent, has appointed Serina Filler as its first group clinical director.

The veterinary surgeon, industry speaker and published author will take on a leadership role at the group.

Dr Filler began her veterinary training in Austria, before completing her final year at Washington State University, USA. During her studies in Austria, Dr Filler ran a cat rescue network and, after qualifying, she worked in private clinics and a teaching hospital in Germany.

She studied for her postgraduate certificate in the UK, spending three years studying under professor Severine Tasker for her PhD in feline hemoplasmas.

Dr Filler went on to work at the London Cat Clinic, where she gained a clinical qualification in feline medicine and supported its transition to a 24-hour hospital. After a stint in a non-practice role, she returned to practice as a clinical lead at a subscription-based start-up.

In her role at Pennard Vets, Dr Filler will be mentoring and leading the clinical teams, as well as developing new protocols across the group. Her role will also involve strategic business planning and workflow improvements.

Dr Filler said: “From everything I know about Pennard Vets, it’s a place where people do the right thing, there is a genuine commitment to its teams, clients and pets to deliver excellence in veterinary care, and I can’t wait to be a part of that.”

Founded in 1890, Pennard Vets is an independent veterinary group consisting of eight practices across Kent.

In 2021, it became the largest practice in the world to transfer into employee ownership within an employee ownership trust (EOT). It also became B-Corp certified in 2022 – meaning it has displayed high standards of social and environmental performance, public transparency and legal accountability.

Matthew Flann, from Pennard Vets, said: “Having become an employee ownership trust, B-Corp certified and expanding to eight practices, as well as opening our brand-new state of the art practice in Sevenoaks, all in recent years, we felt now was the right time to create a new role of group clinical director.

“Serina’s qualifications, experience and personality made her the ideal fit for this position, and we can’t wait to see how the changes she implements benefit everyone associated with Pennard Vets.”

Image © Pennard Vets

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.